BrainStorm Cell Therapeutics
BCLI
#10185
Rank
HK$50.99 M
Marketcap
HK$8.94
Share price
-6.50%
Change (1 day)
-88.29%
Change (1 year)

EPS for BrainStorm Cell Therapeutics (BCLI)

EPS in 2023 (TTM): -HK$4.63

According to BrainStorm Cell Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$4.59. In 2022 the company made an earnings per share (EPS) of -HK$5.13 an increase over its 2021 EPS that were of -HK$5.29.

EPS history for BrainStorm Cell Therapeutics from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$4.63-9.86%
2022-HK$5.13-2.94%
2021-HK$5.29-37.04%
2020-HK$8.401.89%
2019-HK$8.2451.43%
2018-HK$5.44159.26%
2017-HK$2.10-3.57%
2016-HK$2.18-37.78%
2015-HK$3.50-33.82%
2014-HK$5.2936%
2013-HK$3.8911.11%
2012-HK$3.5050%
2011-HK$2.33-50%
2010-HK$4.66-233.33%
2009HK$3.50-142.86%
2008-HK$8.16-65%
2007-HK$23.32
2005HK$7.70-108.03%
2004-HK$95.8913203.07%
2003-HK$0.72

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
HK$34.13-844.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$44.24 864.41%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$31.17 579.66%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$143.51-3,228.81%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$6.61 44.07%๐Ÿ‡บ๐Ÿ‡ธ USA